UPDATE
1-Galenica to buy
biotech firm Relypsa for
.5 bln
before break-up
July 21 (Reuters) - Galenica has agreed to buy U.S.biotech
firm Relypsa for $1.53 billion in cash tostrengthen its Vifor Pharma unit ahead of splitting up the Swisshealthcare group.